Ribociclib and Mefloquine: Interaction Details
- Ribociclib
- Kisqali
- Mefloquine
- Lariam
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Ribociclib and Mefloquine interaction:
What Happens When You Take Ribociclib With Mefloquine
What can happen when they are taken together (rated Major)
An increased risk of
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Ribociclib should not be given together with drugs known to have the potential to prolong the , since the combination may lead to greater QT prolongation. When such is unavoidable, monitoring is advised at the start of therapy, throughout the period of combined use, and whenever otherwise needed.
If QTcF (QT interval corrected by the Fridericia formula) exceeds 480 ms but is no higher than 500 ms, the approach depends on the indication. In early breast cancer, ribociclib is interrupted until QTcF returns to below 480 ms, and then restarted at the same dose.
In advanced or metastatic breast cancer, ribociclib is likewise interrupted until QTcF returns to below 480 ms, but it is then restarted at the next lower dose level. In that setting, if QTcF above 480 ms occurs again, ribociclib is interrupted once more until QTcF is below 480 ms, and treatment resumes at the next lower dose level.
If QTcF is greater than 500 ms, ribociclib is interrupted until QTcF falls below 480 ms and is then resumed at the next lower dose level. A recurrence of QTcF above 500 ms calls for discontinuation of ribociclib.
Ribociclib must also be permanently discontinued when QTcF prolongation is either above 500 ms or a change of more than 60 ms from baseline, and is accompanied by torsade's de pointes, polymorphic ventricular , syncope, or signs or symptoms of serious . Ribociclib should be discontinued if a dose reduction to below 200 mg/day would be needed.1
The Ribociclib and Mefloquine Interaction, Explained
Both of these medicines can affect your heart's electrical rhythm. Ribociclib (Kisqali), a breast cancer medicine, and mefloquine (Lariam), a malaria medicine, can each lengthen a heart timing measure called the . Taking them together could add up and raise the chance of a fast, irregular heartbeat, which can cause dizziness or fainting. This risk is based on how the drugs work rather than on studies of the two together.
Your care team may choose a different option, or they may check your heart with an tracing and adjust your ribociclib dose. Please talk with your pharmacist or doctor before taking both, and do not change anything on your own.
() between ribociclib and mefloquine. Evidence is theoretical, with no direct interaction data. Onset is unspecified. Severity is rated major.
- Avoid where possible.
- If unavoidable, obtain a baseline , then monitor during concomitant use and as needed. Also consider electrolytes (K, Mg, Ca).
- QTcF >480 to 500 ms: interrupt ribociclib until QTcF is 500 ms: interrupt until 500 ms or a change from baseline >60 ms occurs with , polymorphic VT, syncope, or serious signs. Discontinue if a dose below 200 mg/day is required.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Ribociclib and Mefloquine Interact
The likely mechanism
How to Manage the Ribociclib and Mefloquine Interaction
Your care team can manage this. The safest approach is usually to avoid using these two together. If both are truly needed, your team will typically:
- Check your heart rhythm with an when you start and during treatment.
- Temporarily pause ribociclib if the ECG shows the is too long, then restart it once it improves, possibly at a lower dose that is individualized for you.
What you can do: keep taking your medicines as prescribed unless told otherwise, and tell your pharmacist or prescriber about all your medicines. Seek prompt care for fainting, a racing or pounding heartbeat, or severe dizziness.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Ribociclib or Mefloquine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Ribociclib and Mefloquine: Common Questions
How serious is the Ribociclib and Mefloquine interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Ribociclib and Mefloquine interaction managed?
Your care team can manage this. The safest approach is usually to avoid using these two together. If both are truly needed, your team will typically: Check your heart rhythm with an when you start and during treatment. Temporarily pause ribociclib if the ECG shows the is too long, then restart it once it improves, possibly at a lower dose that is individualized for you. What you ca… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Ribociclib and Mefloquine Interaction
Ask in your own words about taking Ribociclib and Mefloquine together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: KISQALI(R) oral tablets, ribociclib oral tablets. Novartis Pharmaceuticals Corporation (per FDA), East Hanover, NJ, 2025. DailyMed
Other Serious Interactions of Ribociclib and Mefloquine
Also serious with Ribociclib
- ColchicineContraindicated
- SimvastatinContraindicated
- Dihydroergotamine InjectionContraindicated
- Dihydroergotamine Nasal SprayContraindicated
Also serious with Mefloquine
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Mefloquine
- Activated CharcoalMajor
- GinkgoModerate
- MelatoninModerate
- Slippery ElmModerate
- GlucomannanModerate
- TragacanthModerate
- BiofeedbackModerate
- Coffee CharcoalModerate
- + 15 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.